Skip to main content
Premium Trial:

Request an Annual Quote

Oncocyte: John Peter Gutfreund

Oncocyte's board of directors has elected John Peter Gutfreund as a new independent director, with a term that expires at the company's 2023 annual stockholder meeting or until his earlier resignation or removal. Gutfreund, who will chair the board's finance committee and will serve on its compensation committee, has served as managing Partner of Halle Capital Management since October 2019. He also serves on the board of several Halle portfolio companies and is a trustee at Montefiore Health System. Prior to joining Halle Capital Management, Gutfreund was director of research at Glenview Capital Management, He holds a BA from New York University.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find structural network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.